{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.666.5.2328","meta":{"versionId":"50","lastUpdated":"2020-03-06T01:00:20.000-05:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Immunocompromised Conditions I10</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://hl7.org/fhir/sid/icd-10-cm</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>B20</td>\n              <td>Human immunodeficiency virus [HIV] disease</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>B97.35</td>\n              <td>Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.00</td>\n              <td>Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.01</td>\n              <td>Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.02</td>\n              <td>Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.03</td>\n              <td>Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.04</td>\n              <td>Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.05</td>\n              <td>Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.06</td>\n              <td>Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.07</td>\n              <td>Nodular lymphocyte predominant Hodgkin lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.08</td>\n              <td>Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.09</td>\n              <td>Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.10</td>\n              <td>Nodular sclerosis Hodgkin lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.11</td>\n              <td>Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.12</td>\n              <td>Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.13</td>\n              <td>Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.14</td>\n              <td>Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.15</td>\n              <td>Nodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.16</td>\n              <td>Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.17</td>\n              <td>Nodular sclerosis Hodgkin lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.18</td>\n              <td>Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.19</td>\n              <td>Nodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.20</td>\n              <td>Mixed cellularity Hodgkin lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.21</td>\n              <td>Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.22</td>\n              <td>Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.23</td>\n              <td>Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.24</td>\n              <td>Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.25</td>\n              <td>Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.26</td>\n              <td>Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.27</td>\n              <td>Mixed cellularity Hodgkin lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.28</td>\n              <td>Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.29</td>\n              <td>Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.30</td>\n              <td>Lymphocyte depleted Hodgkin lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.31</td>\n              <td>Lymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.32</td>\n              <td>Lymphocyte depleted Hodgkin lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.33</td>\n              <td>Lymphocyte depleted Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.34</td>\n              <td>Lymphocyte depleted Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.35</td>\n              <td>Lymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.36</td>\n              <td>Lymphocyte depleted Hodgkin lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.37</td>\n              <td>Lymphocyte depleted Hodgkin lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.38</td>\n              <td>Lymphocyte depleted Hodgkin lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.39</td>\n              <td>Lymphocyte depleted Hodgkin lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.40</td>\n              <td>Lymphocyte-rich Hodgkin lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.41</td>\n              <td>Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.42</td>\n              <td>Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.43</td>\n              <td>Lymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.44</td>\n              <td>Lymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.45</td>\n              <td>Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.46</td>\n              <td>Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.47</td>\n              <td>Lymphocyte-rich Hodgkin lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.48</td>\n              <td>Lymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.49</td>\n              <td>Lymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.70</td>\n              <td>Other Hodgkin lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.71</td>\n              <td>Other Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.72</td>\n              <td>Other Hodgkin lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.73</td>\n              <td>Other Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.74</td>\n              <td>Other Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.75</td>\n              <td>Other Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.76</td>\n              <td>Other Hodgkin lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.77</td>\n              <td>Other Hodgkin lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.78</td>\n              <td>Other Hodgkin lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.79</td>\n              <td>Other Hodgkin lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.90</td>\n              <td>Hodgkin lymphoma, unspecified, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.91</td>\n              <td>Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.92</td>\n              <td>Hodgkin lymphoma, unspecified, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.93</td>\n              <td>Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.94</td>\n              <td>Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.95</td>\n              <td>Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.96</td>\n              <td>Hodgkin lymphoma, unspecified, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.97</td>\n              <td>Hodgkin lymphoma, unspecified, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.98</td>\n              <td>Hodgkin lymphoma, unspecified, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C81.99</td>\n              <td>Hodgkin lymphoma, unspecified, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.00</td>\n              <td>Follicular lymphoma grade I, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.01</td>\n              <td>Follicular lymphoma grade I, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.02</td>\n              <td>Follicular lymphoma grade I, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.03</td>\n              <td>Follicular lymphoma grade I, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.04</td>\n              <td>Follicular lymphoma grade I, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.05</td>\n              <td>Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.06</td>\n              <td>Follicular lymphoma grade I, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.07</td>\n              <td>Follicular lymphoma grade I, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.08</td>\n              <td>Follicular lymphoma grade I, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.09</td>\n              <td>Follicular lymphoma grade I, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.10</td>\n              <td>Follicular lymphoma grade II, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.11</td>\n              <td>Follicular lymphoma grade II, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.12</td>\n              <td>Follicular lymphoma grade II, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.13</td>\n              <td>Follicular lymphoma grade II, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.14</td>\n              <td>Follicular lymphoma grade II, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.15</td>\n              <td>Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.16</td>\n              <td>Follicular lymphoma grade II, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.17</td>\n              <td>Follicular lymphoma grade II, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.18</td>\n              <td>Follicular lymphoma grade II, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.19</td>\n              <td>Follicular lymphoma grade II, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.20</td>\n              <td>Follicular lymphoma grade III, unspecified, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.21</td>\n              <td>Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.22</td>\n              <td>Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.23</td>\n              <td>Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.24</td>\n              <td>Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.25</td>\n              <td>Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.26</td>\n              <td>Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.27</td>\n              <td>Follicular lymphoma grade III, unspecified, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.28</td>\n              <td>Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.29</td>\n              <td>Follicular lymphoma grade III, unspecified, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.30</td>\n              <td>Follicular lymphoma grade IIIa, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.31</td>\n              <td>Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.32</td>\n              <td>Follicular lymphoma grade IIIa, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.33</td>\n              <td>Follicular lymphoma grade IIIa, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.34</td>\n              <td>Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.35</td>\n              <td>Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.36</td>\n              <td>Follicular lymphoma grade IIIa, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.37</td>\n              <td>Follicular lymphoma grade IIIa, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.38</td>\n              <td>Follicular lymphoma grade IIIa, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.39</td>\n              <td>Follicular lymphoma grade IIIa, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.40</td>\n              <td>Follicular lymphoma grade IIIb, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.41</td>\n              <td>Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.42</td>\n              <td>Follicular lymphoma grade IIIb, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.43</td>\n              <td>Follicular lymphoma grade IIIb, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.44</td>\n              <td>Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.45</td>\n              <td>Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.46</td>\n              <td>Follicular lymphoma grade IIIb, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.47</td>\n              <td>Follicular lymphoma grade IIIb, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.48</td>\n              <td>Follicular lymphoma grade IIIb, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.49</td>\n              <td>Follicular lymphoma grade IIIb, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.50</td>\n              <td>Diffuse follicle center lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.51</td>\n              <td>Diffuse follicle center lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.52</td>\n              <td>Diffuse follicle center lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.53</td>\n              <td>Diffuse follicle center lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.54</td>\n              <td>Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.55</td>\n              <td>Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.56</td>\n              <td>Diffuse follicle center lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.57</td>\n              <td>Diffuse follicle center lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.58</td>\n              <td>Diffuse follicle center lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.59</td>\n              <td>Diffuse follicle center lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.60</td>\n              <td>Cutaneous follicle center lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.61</td>\n              <td>Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.62</td>\n              <td>Cutaneous follicle center lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.63</td>\n              <td>Cutaneous follicle center lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.64</td>\n              <td>Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.65</td>\n              <td>Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.66</td>\n              <td>Cutaneous follicle center lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.67</td>\n              <td>Cutaneous follicle center lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.68</td>\n              <td>Cutaneous follicle center lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.69</td>\n              <td>Cutaneous follicle center lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.80</td>\n              <td>Other types of follicular lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.81</td>\n              <td>Other types of follicular lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.82</td>\n              <td>Other types of follicular lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.83</td>\n              <td>Other types of follicular lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.84</td>\n              <td>Other types of follicular lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.85</td>\n              <td>Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.86</td>\n              <td>Other types of follicular lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.87</td>\n              <td>Other types of follicular lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.88</td>\n              <td>Other types of follicular lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.89</td>\n              <td>Other types of follicular lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.90</td>\n              <td>Follicular lymphoma, unspecified, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.91</td>\n              <td>Follicular lymphoma, unspecified, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.92</td>\n              <td>Follicular lymphoma, unspecified, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.93</td>\n              <td>Follicular lymphoma, unspecified, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.94</td>\n              <td>Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.95</td>\n              <td>Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.96</td>\n              <td>Follicular lymphoma, unspecified, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.97</td>\n              <td>Follicular lymphoma, unspecified, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.98</td>\n              <td>Follicular lymphoma, unspecified, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C82.99</td>\n              <td>Follicular lymphoma, unspecified, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.10</td>\n              <td>Mantle cell lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.11</td>\n              <td>Mantle cell lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.12</td>\n              <td>Mantle cell lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.13</td>\n              <td>Mantle cell lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.14</td>\n              <td>Mantle cell lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.15</td>\n              <td>Mantle cell lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.16</td>\n              <td>Mantle cell lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.17</td>\n              <td>Mantle cell lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.18</td>\n              <td>Mantle cell lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.19</td>\n              <td>Mantle cell lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.31</td>\n              <td>Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.32</td>\n              <td>Diffuse large B-cell lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.33</td>\n              <td>Diffuse large B-cell lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.34</td>\n              <td>Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.35</td>\n              <td>Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.36</td>\n              <td>Diffuse large B-cell lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.37</td>\n              <td>Diffuse large B-cell lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.38</td>\n              <td>Diffuse large B-cell lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.39</td>\n              <td>Diffuse large B-cell lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.70</td>\n              <td>Burkitt lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.71</td>\n              <td>Burkitt lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.72</td>\n              <td>Burkitt lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.73</td>\n              <td>Burkitt lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.74</td>\n              <td>Burkitt lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.75</td>\n              <td>Burkitt lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.76</td>\n              <td>Burkitt lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.77</td>\n              <td>Burkitt lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.78</td>\n              <td>Burkitt lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.79</td>\n              <td>Burkitt lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.80</td>\n              <td>Other non-follicular lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.81</td>\n              <td>Other non-follicular lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.82</td>\n              <td>Other non-follicular lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.83</td>\n              <td>Other non-follicular lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.84</td>\n              <td>Other non-follicular lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.85</td>\n              <td>Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.86</td>\n              <td>Other non-follicular lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.87</td>\n              <td>Other non-follicular lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.88</td>\n              <td>Other non-follicular lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C83.89</td>\n              <td>Other non-follicular lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.40</td>\n              <td>Peripheral T-cell lymphoma, not classified, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.41</td>\n              <td>Peripheral T-cell lymphoma, not classified, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.42</td>\n              <td>Peripheral T-cell lymphoma, not classified, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.43</td>\n              <td>Peripheral T-cell lymphoma, not classified, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.44</td>\n              <td>Peripheral T-cell lymphoma, not classified, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.45</td>\n              <td>Peripheral T-cell lymphoma, not classified, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.46</td>\n              <td>Peripheral T-cell lymphoma, not classified, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.47</td>\n              <td>Peripheral T-cell lymphoma, not classified, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.48</td>\n              <td>Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.49</td>\n              <td>Peripheral T-cell lymphoma, not classified, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.60</td>\n              <td>Anaplastic large cell lymphoma, ALK-positive, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.61</td>\n              <td>Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.62</td>\n              <td>Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.63</td>\n              <td>Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.64</td>\n              <td>Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.65</td>\n              <td>Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.66</td>\n              <td>Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.67</td>\n              <td>Anaplastic large cell lymphoma, ALK-positive, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.68</td>\n              <td>Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.69</td>\n              <td>Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.70</td>\n              <td>Anaplastic large cell lymphoma, ALK-negative, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.71</td>\n              <td>Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.72</td>\n              <td>Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.73</td>\n              <td>Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.74</td>\n              <td>Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.75</td>\n              <td>Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.76</td>\n              <td>Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.77</td>\n              <td>Anaplastic large cell lymphoma, ALK-negative, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.78</td>\n              <td>Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.79</td>\n              <td>Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.90</td>\n              <td>Mature T/NK-cell lymphomas, unspecified, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.91</td>\n              <td>Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.92</td>\n              <td>Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.93</td>\n              <td>Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.94</td>\n              <td>Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.95</td>\n              <td>Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.96</td>\n              <td>Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.97</td>\n              <td>Mature T/NK-cell lymphomas, unspecified, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.98</td>\n              <td>Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.99</td>\n              <td>Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.A0</td>\n              <td>Cutaneous T-cell lymphoma, unspecified, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.A1</td>\n              <td>Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.A2</td>\n              <td>Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.A3</td>\n              <td>Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.A4</td>\n              <td>Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.A5</td>\n              <td>Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.A6</td>\n              <td>Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.A7</td>\n              <td>Cutaneous T-cell lymphoma, unspecified, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.A8</td>\n              <td>Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.A9</td>\n              <td>Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.Z0</td>\n              <td>Other mature T/NK-cell lymphomas, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.Z1</td>\n              <td>Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.Z2</td>\n              <td>Other mature T/NK-cell lymphomas, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.Z3</td>\n              <td>Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.Z4</td>\n              <td>Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.Z5</td>\n              <td>Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.Z6</td>\n              <td>Other mature T/NK-cell lymphomas, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.Z7</td>\n              <td>Other mature T/NK-cell lymphomas, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.Z8</td>\n              <td>Other mature T/NK-cell lymphomas, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C84.Z9</td>\n              <td>Other mature T/NK-cell lymphomas, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.10</td>\n              <td>Unspecified B-cell lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.11</td>\n              <td>Unspecified B-cell lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.12</td>\n              <td>Unspecified B-cell lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.13</td>\n              <td>Unspecified B-cell lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.14</td>\n              <td>Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.15</td>\n              <td>Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.16</td>\n              <td>Unspecified B-cell lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.17</td>\n              <td>Unspecified B-cell lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.18</td>\n              <td>Unspecified B-cell lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.19</td>\n              <td>Unspecified B-cell lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.20</td>\n              <td>Mediastinal (thymic) large B-cell lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.21</td>\n              <td>Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.22</td>\n              <td>Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.23</td>\n              <td>Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.24</td>\n              <td>Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.25</td>\n              <td>Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.26</td>\n              <td>Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.27</td>\n              <td>Mediastinal (thymic) large B-cell lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.28</td>\n              <td>Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.29</td>\n              <td>Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.80</td>\n              <td>Other specified types of non-Hodgkin lymphoma, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.81</td>\n              <td>Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.82</td>\n              <td>Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.83</td>\n              <td>Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.84</td>\n              <td>Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.85</td>\n              <td>Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.86</td>\n              <td>Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.87</td>\n              <td>Other specified types of non-Hodgkin lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.88</td>\n              <td>Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.89</td>\n              <td>Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.90</td>\n              <td>Non-Hodgkin lymphoma, unspecified, unspecified site</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.91</td>\n              <td>Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.92</td>\n              <td>Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.93</td>\n              <td>Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.94</td>\n              <td>Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.95</td>\n              <td>Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.96</td>\n              <td>Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.97</td>\n              <td>Non-Hodgkin lymphoma, unspecified, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.98</td>\n              <td>Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C85.99</td>\n              <td>Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C86.0</td>\n              <td>Extranodal NK/T-cell lymphoma, nasal type</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C86.1</td>\n              <td>Hepatosplenic T-cell lymphoma</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C86.2</td>\n              <td>Enteropathy-type (intestinal) T-cell lymphoma</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C86.3</td>\n              <td>Subcutaneous panniculitis-like T-cell lymphoma</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C86.4</td>\n              <td>Blastic NK-cell lymphoma</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C86.6</td>\n              <td>Primary cutaneous CD30-positive T-cell proliferations</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C88.4</td>\n              <td>Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C90.00</td>\n              <td>Multiple myeloma not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C90.02</td>\n              <td>Multiple myeloma in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C90.10</td>\n              <td>Plasma cell leukemia not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C90.12</td>\n              <td>Plasma cell leukemia in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.00</td>\n              <td>Acute lymphoblastic leukemia not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.02</td>\n              <td>Acute lymphoblastic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.30</td>\n              <td>Prolymphocytic leukemia of B-cell type not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.32</td>\n              <td>Prolymphocytic leukemia of B-cell type, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.50</td>\n              <td>Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.52</td>\n              <td>Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.60</td>\n              <td>Prolymphocytic leukemia of T-cell type not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.62</td>\n              <td>Prolymphocytic leukemia of T-cell type, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.90</td>\n              <td>Lymphoid leukemia, unspecified not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.92</td>\n              <td>Lymphoid leukemia, unspecified, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.A0</td>\n              <td>Mature B-cell leukemia Burkitt-type not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.A2</td>\n              <td>Mature B-cell leukemia Burkitt-type, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.Z0</td>\n              <td>Other lymphoid leukemia not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C91.Z2</td>\n              <td>Other lymphoid leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.00</td>\n              <td>Acute myeloblastic leukemia, not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.02</td>\n              <td>Acute myeloblastic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.10</td>\n              <td>Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.12</td>\n              <td>Chronic myeloid leukemia, BCR/ABL-positive, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.20</td>\n              <td>Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.22</td>\n              <td>Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.40</td>\n              <td>Acute promyelocytic leukemia, not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.42</td>\n              <td>Acute promyelocytic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.50</td>\n              <td>Acute myelomonocytic leukemia, not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.52</td>\n              <td>Acute myelomonocytic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.60</td>\n              <td>Acute myeloid leukemia with 11q23-abnormality not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.62</td>\n              <td>Acute myeloid leukemia with 11q23-abnormality in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.90</td>\n              <td>Myeloid leukemia, unspecified, not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.92</td>\n              <td>Myeloid leukemia, unspecified in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.A0</td>\n              <td>Acute myeloid leukemia with multilineage dysplasia, not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.A2</td>\n              <td>Acute myeloid leukemia with multilineage dysplasia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.Z0</td>\n              <td>Other myeloid leukemia not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C92.Z2</td>\n              <td>Other myeloid leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C93.00</td>\n              <td>Acute monoblastic/monocytic leukemia, not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C93.02</td>\n              <td>Acute monoblastic/monocytic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C93.10</td>\n              <td>Chronic myelomonocytic leukemia not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C93.12</td>\n              <td>Chronic myelomonocytic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C93.30</td>\n              <td>Juvenile myelomonocytic leukemia, not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C93.32</td>\n              <td>Juvenile myelomonocytic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C93.90</td>\n              <td>Monocytic leukemia, unspecified, not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C93.92</td>\n              <td>Monocytic leukemia, unspecified in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C93.Z0</td>\n              <td>Other monocytic leukemia, not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C93.Z2</td>\n              <td>Other monocytic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C94.20</td>\n              <td>Acute megakaryoblastic leukemia not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C94.22</td>\n              <td>Acute megakaryoblastic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C94.30</td>\n              <td>Mast cell leukemia not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C94.32</td>\n              <td>Mast cell leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C94.80</td>\n              <td>Other specified leukemias not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C94.82</td>\n              <td>Other specified leukemias, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C95.00</td>\n              <td>Acute leukemia of unspecified cell type not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C95.02</td>\n              <td>Acute leukemia of unspecified cell type, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C95.10</td>\n              <td>Chronic leukemia of unspecified cell type not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C95.12</td>\n              <td>Chronic leukemia of unspecified cell type, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C95.90</td>\n              <td>Leukemia, unspecified not having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C95.92</td>\n              <td>Leukemia, unspecified, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C96.4</td>\n              <td>Sarcoma of dendritic cells (accessory cells)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C96.9</td>\n              <td>Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>C96.Z</td>\n              <td>Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D46.9</td>\n              <td>Myelodysplastic syndrome, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D46.Z</td>\n              <td>Other myelodysplastic syndromes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D61.818</td>\n              <td>Other pancytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D70.0</td>\n              <td>Congenital agranulocytosis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D70.3</td>\n              <td>Neutropenia due to infection</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D70.4</td>\n              <td>Cyclic neutropenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D70.8</td>\n              <td>Other neutropenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D70.9</td>\n              <td>Neutropenia, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D73.81</td>\n              <td>Neutropenic splenomegaly</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.0</td>\n              <td>Hereditary hypogammaglobulinemia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.1</td>\n              <td>Nonfamilial hypogammaglobulinemia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.2</td>\n              <td>Selective deficiency of immunoglobulin A [IgA]</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.7</td>\n              <td>Transient hypogammaglobulinemia of infancy</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.8</td>\n              <td>Other immunodeficiencies with predominantly antibody defects</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D80.9</td>\n              <td>Immunodeficiency with predominantly antibody defects, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.0</td>\n              <td>Severe combined immunodeficiency [SCID] with reticular dysgenesis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.1</td>\n              <td>Severe combined immunodeficiency [SCID] with low T- and B-cell numbers</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.2</td>\n              <td>Severe combined immunodeficiency [SCID] with low or normal B-cell numbers</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.31</td>\n              <td>Severe combined immunodeficiency due to adenosine deaminase deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.89</td>\n              <td>Other combined immunodeficiencies</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D81.9</td>\n              <td>Combined immunodeficiency, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D82.0</td>\n              <td>Wiskott-Aldrich syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D82.3</td>\n              <td>Immunodeficiency following hereditary defective response to Epstein-Barr virus</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D82.8</td>\n              <td>Immunodeficiency associated with other specified major defects</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D82.9</td>\n              <td>Immunodeficiency associated with major defect, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D83.0</td>\n              <td>Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D83.1</td>\n              <td>Common variable immunodeficiency with predominant immunoregulatory T-cell disorders</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D83.2</td>\n              <td>Common variable immunodeficiency with autoantibodies to B- or T-cells</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D83.8</td>\n              <td>Other common variable immunodeficiencies</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D83.9</td>\n              <td>Common variable immunodeficiency, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D84.1</td>\n              <td>Defects in the complement system</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D84.8</td>\n              <td>Other specified immunodeficiencies</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>D84.9</td>\n              <td>Immunodeficiency, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>E70.330</td>\n              <td>Chediak-Higashi syndrome</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2328","version":"20200306","name":"Immunocompromised Conditions I10","status":"active","date":"2020-03-06T01:00:20-05:00","publisher":"Oregon Urology Steward","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","concept":[{"code":"B20","display":"Human immunodeficiency virus [HIV] disease"},{"code":"B97.35","display":"Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere"},{"code":"C81.00","display":"Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site"},{"code":"C81.01","display":"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C81.02","display":"Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C81.03","display":"Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C81.04","display":"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C81.05","display":"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C81.06","display":"Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C81.07","display":"Nodular lymphocyte predominant Hodgkin lymphoma, spleen"},{"code":"C81.08","display":"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C81.09","display":"Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C81.10","display":"Nodular sclerosis Hodgkin lymphoma, unspecified site"},{"code":"C81.11","display":"Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C81.12","display":"Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C81.13","display":"Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C81.14","display":"Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C81.15","display":"Nodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C81.16","display":"Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C81.17","display":"Nodular sclerosis Hodgkin lymphoma, spleen"},{"code":"C81.18","display":"Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C81.19","display":"Nodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C81.20","display":"Mixed cellularity Hodgkin lymphoma, unspecified site"},{"code":"C81.21","display":"Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C81.22","display":"Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C81.23","display":"Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C81.24","display":"Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C81.25","display":"Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C81.26","display":"Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C81.27","display":"Mixed cellularity Hodgkin lymphoma, spleen"},{"code":"C81.28","display":"Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C81.29","display":"Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C81.30","display":"Lymphocyte depleted Hodgkin lymphoma, unspecified site"},{"code":"C81.31","display":"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C81.32","display":"Lymphocyte depleted Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C81.33","display":"Lymphocyte depleted Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C81.34","display":"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C81.35","display":"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C81.36","display":"Lymphocyte depleted Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C81.37","display":"Lymphocyte depleted Hodgkin lymphoma, spleen"},{"code":"C81.38","display":"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C81.39","display":"Lymphocyte depleted Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C81.40","display":"Lymphocyte-rich Hodgkin lymphoma, unspecified site"},{"code":"C81.41","display":"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C81.42","display":"Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C81.43","display":"Lymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C81.44","display":"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C81.45","display":"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C81.46","display":"Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C81.47","display":"Lymphocyte-rich Hodgkin lymphoma, spleen"},{"code":"C81.48","display":"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C81.49","display":"Lymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C81.70","display":"Other Hodgkin lymphoma, unspecified site"},{"code":"C81.71","display":"Other Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C81.72","display":"Other Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C81.73","display":"Other Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C81.74","display":"Other Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C81.75","display":"Other Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C81.76","display":"Other Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C81.77","display":"Other Hodgkin lymphoma, spleen"},{"code":"C81.78","display":"Other Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C81.79","display":"Other Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C81.90","display":"Hodgkin lymphoma, unspecified, unspecified site"},{"code":"C81.91","display":"Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck"},{"code":"C81.92","display":"Hodgkin lymphoma, unspecified, intrathoracic lymph nodes"},{"code":"C81.93","display":"Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes"},{"code":"C81.94","display":"Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb"},{"code":"C81.95","display":"Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb"},{"code":"C81.96","display":"Hodgkin lymphoma, unspecified, intrapelvic lymph nodes"},{"code":"C81.97","display":"Hodgkin lymphoma, unspecified, spleen"},{"code":"C81.98","display":"Hodgkin lymphoma, unspecified, lymph nodes of multiple sites"},{"code":"C81.99","display":"Hodgkin lymphoma, unspecified, extranodal and solid organ sites"},{"code":"C82.00","display":"Follicular lymphoma grade I, unspecified site"},{"code":"C82.01","display":"Follicular lymphoma grade I, lymph nodes of head, face, and neck"},{"code":"C82.02","display":"Follicular lymphoma grade I, intrathoracic lymph nodes"},{"code":"C82.03","display":"Follicular lymphoma grade I, intra-abdominal lymph nodes"},{"code":"C82.04","display":"Follicular lymphoma grade I, lymph nodes of axilla and upper limb"},{"code":"C82.05","display":"Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb"},{"code":"C82.06","display":"Follicular lymphoma grade I, intrapelvic lymph nodes"},{"code":"C82.07","display":"Follicular lymphoma grade I, spleen"},{"code":"C82.08","display":"Follicular lymphoma grade I, lymph nodes of multiple sites"},{"code":"C82.09","display":"Follicular lymphoma grade I, extranodal and solid organ sites"},{"code":"C82.10","display":"Follicular lymphoma grade II, unspecified site"},{"code":"C82.11","display":"Follicular lymphoma grade II, lymph nodes of head, face, and neck"},{"code":"C82.12","display":"Follicular lymphoma grade II, intrathoracic lymph nodes"},{"code":"C82.13","display":"Follicular lymphoma grade II, intra-abdominal lymph nodes"},{"code":"C82.14","display":"Follicular lymphoma grade II, lymph nodes of axilla and upper limb"},{"code":"C82.15","display":"Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb"},{"code":"C82.16","display":"Follicular lymphoma grade II, intrapelvic lymph nodes"},{"code":"C82.17","display":"Follicular lymphoma grade II, spleen"},{"code":"C82.18","display":"Follicular lymphoma grade II, lymph nodes of multiple sites"},{"code":"C82.19","display":"Follicular lymphoma grade II, extranodal and solid organ sites"},{"code":"C82.20","display":"Follicular lymphoma grade III, unspecified, unspecified site"},{"code":"C82.21","display":"Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck"},{"code":"C82.22","display":"Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes"},{"code":"C82.23","display":"Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes"},{"code":"C82.24","display":"Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb"},{"code":"C82.25","display":"Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb"},{"code":"C82.26","display":"Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes"},{"code":"C82.27","display":"Follicular lymphoma grade III, unspecified, spleen"},{"code":"C82.28","display":"Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites"},{"code":"C82.29","display":"Follicular lymphoma grade III, unspecified, extranodal and solid organ sites"},{"code":"C82.30","display":"Follicular lymphoma grade IIIa, unspecified site"},{"code":"C82.31","display":"Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck"},{"code":"C82.32","display":"Follicular lymphoma grade IIIa, intrathoracic lymph nodes"},{"code":"C82.33","display":"Follicular lymphoma grade IIIa, intra-abdominal lymph nodes"},{"code":"C82.34","display":"Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb"},{"code":"C82.35","display":"Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb"},{"code":"C82.36","display":"Follicular lymphoma grade IIIa, intrapelvic lymph nodes"},{"code":"C82.37","display":"Follicular lymphoma grade IIIa, spleen"},{"code":"C82.38","display":"Follicular lymphoma grade IIIa, lymph nodes of multiple sites"},{"code":"C82.39","display":"Follicular lymphoma grade IIIa, extranodal and solid organ sites"},{"code":"C82.40","display":"Follicular lymphoma grade IIIb, unspecified site"},{"code":"C82.41","display":"Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck"},{"code":"C82.42","display":"Follicular lymphoma grade IIIb, intrathoracic lymph nodes"},{"code":"C82.43","display":"Follicular lymphoma grade IIIb, intra-abdominal lymph nodes"},{"code":"C82.44","display":"Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb"},{"code":"C82.45","display":"Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb"},{"code":"C82.46","display":"Follicular lymphoma grade IIIb, intrapelvic lymph nodes"},{"code":"C82.47","display":"Follicular lymphoma grade IIIb, spleen"},{"code":"C82.48","display":"Follicular lymphoma grade IIIb, lymph nodes of multiple sites"},{"code":"C82.49","display":"Follicular lymphoma grade IIIb, extranodal and solid organ sites"},{"code":"C82.50","display":"Diffuse follicle center lymphoma, unspecified site"},{"code":"C82.51","display":"Diffuse follicle center lymphoma, lymph nodes of head, face, and neck"},{"code":"C82.52","display":"Diffuse follicle center lymphoma, intrathoracic lymph nodes"},{"code":"C82.53","display":"Diffuse follicle center lymphoma, intra-abdominal lymph nodes"},{"code":"C82.54","display":"Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb"},{"code":"C82.55","display":"Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C82.56","display":"Diffuse follicle center lymphoma, intrapelvic lymph nodes"},{"code":"C82.57","display":"Diffuse follicle center lymphoma, spleen"},{"code":"C82.58","display":"Diffuse follicle center lymphoma, lymph nodes of multiple sites"},{"code":"C82.59","display":"Diffuse follicle center lymphoma, extranodal and solid organ sites"},{"code":"C82.60","display":"Cutaneous follicle center lymphoma, unspecified site"},{"code":"C82.61","display":"Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck"},{"code":"C82.62","display":"Cutaneous follicle center lymphoma, intrathoracic lymph nodes"},{"code":"C82.63","display":"Cutaneous follicle center lymphoma, intra-abdominal lymph nodes"},{"code":"C82.64","display":"Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb"},{"code":"C82.65","display":"Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C82.66","display":"Cutaneous follicle center lymphoma, intrapelvic lymph nodes"},{"code":"C82.67","display":"Cutaneous follicle center lymphoma, spleen"},{"code":"C82.68","display":"Cutaneous follicle center lymphoma, lymph nodes of multiple sites"},{"code":"C82.69","display":"Cutaneous follicle center lymphoma, extranodal and solid organ sites"},{"code":"C82.80","display":"Other types of follicular lymphoma, unspecified site"},{"code":"C82.81","display":"Other types of follicular lymphoma, lymph nodes of head, face, and neck"},{"code":"C82.82","display":"Other types of follicular lymphoma, intrathoracic lymph nodes"},{"code":"C82.83","display":"Other types of follicular lymphoma, intra-abdominal lymph nodes"},{"code":"C82.84","display":"Other types of follicular lymphoma, lymph nodes of axilla and upper limb"},{"code":"C82.85","display":"Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C82.86","display":"Other types of follicular lymphoma, intrapelvic lymph nodes"},{"code":"C82.87","display":"Other types of follicular lymphoma, spleen"},{"code":"C82.88","display":"Other types of follicular lymphoma, lymph nodes of multiple sites"},{"code":"C82.89","display":"Other types of follicular lymphoma, extranodal and solid organ sites"},{"code":"C82.90","display":"Follicular lymphoma, unspecified, unspecified site"},{"code":"C82.91","display":"Follicular lymphoma, unspecified, lymph nodes of head, face, and neck"},{"code":"C82.92","display":"Follicular lymphoma, unspecified, intrathoracic lymph nodes"},{"code":"C82.93","display":"Follicular lymphoma, unspecified, intra-abdominal lymph nodes"},{"code":"C82.94","display":"Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb"},{"code":"C82.95","display":"Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb"},{"code":"C82.96","display":"Follicular lymphoma, unspecified, intrapelvic lymph nodes"},{"code":"C82.97","display":"Follicular lymphoma, unspecified, spleen"},{"code":"C82.98","display":"Follicular lymphoma, unspecified, lymph nodes of multiple sites"},{"code":"C82.99","display":"Follicular lymphoma, unspecified, extranodal and solid organ sites"},{"code":"C83.10","display":"Mantle cell lymphoma, unspecified site"},{"code":"C83.11","display":"Mantle cell lymphoma, lymph nodes of head, face, and neck"},{"code":"C83.12","display":"Mantle cell lymphoma, intrathoracic lymph nodes"},{"code":"C83.13","display":"Mantle cell lymphoma, intra-abdominal lymph nodes"},{"code":"C83.14","display":"Mantle cell lymphoma, lymph nodes of axilla and upper limb"},{"code":"C83.15","display":"Mantle cell lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C83.16","display":"Mantle cell lymphoma, intrapelvic lymph nodes"},{"code":"C83.17","display":"Mantle cell lymphoma, spleen"},{"code":"C83.18","display":"Mantle cell lymphoma, lymph nodes of multiple sites"},{"code":"C83.19","display":"Mantle cell lymphoma, extranodal and solid organ sites"},{"code":"C83.31","display":"Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck"},{"code":"C83.32","display":"Diffuse large B-cell lymphoma, intrathoracic lymph nodes"},{"code":"C83.33","display":"Diffuse large B-cell lymphoma, intra-abdominal lymph nodes"},{"code":"C83.34","display":"Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb"},{"code":"C83.35","display":"Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C83.36","display":"Diffuse large B-cell lymphoma, intrapelvic lymph nodes"},{"code":"C83.37","display":"Diffuse large B-cell lymphoma, spleen"},{"code":"C83.38","display":"Diffuse large B-cell lymphoma, lymph nodes of multiple sites"},{"code":"C83.39","display":"Diffuse large B-cell lymphoma, extranodal and solid organ sites"},{"code":"C83.70","display":"Burkitt lymphoma, unspecified site"},{"code":"C83.71","display":"Burkitt lymphoma, lymph nodes of head, face, and neck"},{"code":"C83.72","display":"Burkitt lymphoma, intrathoracic lymph nodes"},{"code":"C83.73","display":"Burkitt lymphoma, intra-abdominal lymph nodes"},{"code":"C83.74","display":"Burkitt lymphoma, lymph nodes of axilla and upper limb"},{"code":"C83.75","display":"Burkitt lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C83.76","display":"Burkitt lymphoma, intrapelvic lymph nodes"},{"code":"C83.77","display":"Burkitt lymphoma, spleen"},{"code":"C83.78","display":"Burkitt lymphoma, lymph nodes of multiple sites"},{"code":"C83.79","display":"Burkitt lymphoma, extranodal and solid organ sites"},{"code":"C83.80","display":"Other non-follicular lymphoma, unspecified site"},{"code":"C83.81","display":"Other non-follicular lymphoma, lymph nodes of head, face, and neck"},{"code":"C83.82","display":"Other non-follicular lymphoma, intrathoracic lymph nodes"},{"code":"C83.83","display":"Other non-follicular lymphoma, intra-abdominal lymph nodes"},{"code":"C83.84","display":"Other non-follicular lymphoma, lymph nodes of axilla and upper limb"},{"code":"C83.85","display":"Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C83.86","display":"Other non-follicular lymphoma, intrapelvic lymph nodes"},{"code":"C83.87","display":"Other non-follicular lymphoma, spleen"},{"code":"C83.88","display":"Other non-follicular lymphoma, lymph nodes of multiple sites"},{"code":"C83.89","display":"Other non-follicular lymphoma, extranodal and solid organ sites"},{"code":"C84.40","display":"Peripheral T-cell lymphoma, not classified, unspecified site"},{"code":"C84.41","display":"Peripheral T-cell lymphoma, not classified, lymph nodes of head, face, and neck"},{"code":"C84.42","display":"Peripheral T-cell lymphoma, not classified, intrathoracic lymph nodes"},{"code":"C84.43","display":"Peripheral T-cell lymphoma, not classified, intra-abdominal lymph nodes"},{"code":"C84.44","display":"Peripheral T-cell lymphoma, not classified, lymph nodes of axilla and upper limb"},{"code":"C84.45","display":"Peripheral T-cell lymphoma, not classified, lymph nodes of inguinal region and lower limb"},{"code":"C84.46","display":"Peripheral T-cell lymphoma, not classified, intrapelvic lymph nodes"},{"code":"C84.47","display":"Peripheral T-cell lymphoma, not classified, spleen"},{"code":"C84.48","display":"Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites"},{"code":"C84.49","display":"Peripheral T-cell lymphoma, not classified, extranodal and solid organ sites"},{"code":"C84.60","display":"Anaplastic large cell lymphoma, ALK-positive, unspecified site"},{"code":"C84.61","display":"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck"},{"code":"C84.62","display":"Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes"},{"code":"C84.63","display":"Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes"},{"code":"C84.64","display":"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb"},{"code":"C84.65","display":"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb"},{"code":"C84.66","display":"Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes"},{"code":"C84.67","display":"Anaplastic large cell lymphoma, ALK-positive, spleen"},{"code":"C84.68","display":"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites"},{"code":"C84.69","display":"Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites"},{"code":"C84.70","display":"Anaplastic large cell lymphoma, ALK-negative, unspecified site"},{"code":"C84.71","display":"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck"},{"code":"C84.72","display":"Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes"},{"code":"C84.73","display":"Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes"},{"code":"C84.74","display":"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb"},{"code":"C84.75","display":"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb"},{"code":"C84.76","display":"Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes"},{"code":"C84.77","display":"Anaplastic large cell lymphoma, ALK-negative, spleen"},{"code":"C84.78","display":"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites"},{"code":"C84.79","display":"Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites"},{"code":"C84.90","display":"Mature T/NK-cell lymphomas, unspecified, unspecified site"},{"code":"C84.91","display":"Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck"},{"code":"C84.92","display":"Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes"},{"code":"C84.93","display":"Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes"},{"code":"C84.94","display":"Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb"},{"code":"C84.95","display":"Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb"},{"code":"C84.96","display":"Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes"},{"code":"C84.97","display":"Mature T/NK-cell lymphomas, unspecified, spleen"},{"code":"C84.98","display":"Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites"},{"code":"C84.99","display":"Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites"},{"code":"C84.A0","display":"Cutaneous T-cell lymphoma, unspecified, unspecified site"},{"code":"C84.A1","display":"Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck"},{"code":"C84.A2","display":"Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes"},{"code":"C84.A3","display":"Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes"},{"code":"C84.A4","display":"Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb"},{"code":"C84.A5","display":"Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb"},{"code":"C84.A6","display":"Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes"},{"code":"C84.A7","display":"Cutaneous T-cell lymphoma, unspecified, spleen"},{"code":"C84.A8","display":"Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites"},{"code":"C84.A9","display":"Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites"},{"code":"C84.Z0","display":"Other mature T/NK-cell lymphomas, unspecified site"},{"code":"C84.Z1","display":"Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck"},{"code":"C84.Z2","display":"Other mature T/NK-cell lymphomas, intrathoracic lymph nodes"},{"code":"C84.Z3","display":"Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes"},{"code":"C84.Z4","display":"Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb"},{"code":"C84.Z5","display":"Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb"},{"code":"C84.Z6","display":"Other mature T/NK-cell lymphomas, intrapelvic lymph nodes"},{"code":"C84.Z7","display":"Other mature T/NK-cell lymphomas, spleen"},{"code":"C84.Z8","display":"Other mature T/NK-cell lymphomas, lymph nodes of multiple sites"},{"code":"C84.Z9","display":"Other mature T/NK-cell lymphomas, extranodal and solid organ sites"},{"code":"C85.10","display":"Unspecified B-cell lymphoma, unspecified site"},{"code":"C85.11","display":"Unspecified B-cell lymphoma, lymph nodes of head, face, and neck"},{"code":"C85.12","display":"Unspecified B-cell lymphoma, intrathoracic lymph nodes"},{"code":"C85.13","display":"Unspecified B-cell lymphoma, intra-abdominal lymph nodes"},{"code":"C85.14","display":"Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb"},{"code":"C85.15","display":"Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C85.16","display":"Unspecified B-cell lymphoma, intrapelvic lymph nodes"},{"code":"C85.17","display":"Unspecified B-cell lymphoma, spleen"},{"code":"C85.18","display":"Unspecified B-cell lymphoma, lymph nodes of multiple sites"},{"code":"C85.19","display":"Unspecified B-cell lymphoma, extranodal and solid organ sites"},{"code":"C85.20","display":"Mediastinal (thymic) large B-cell lymphoma, unspecified site"},{"code":"C85.21","display":"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck"},{"code":"C85.22","display":"Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes"},{"code":"C85.23","display":"Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes"},{"code":"C85.24","display":"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb"},{"code":"C85.25","display":"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C85.26","display":"Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes"},{"code":"C85.27","display":"Mediastinal (thymic) large B-cell lymphoma, spleen"},{"code":"C85.28","display":"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites"},{"code":"C85.29","display":"Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites"},{"code":"C85.80","display":"Other specified types of non-Hodgkin lymphoma, unspecified site"},{"code":"C85.81","display":"Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C85.82","display":"Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C85.83","display":"Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C85.84","display":"Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C85.85","display":"Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C85.86","display":"Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C85.87","display":"Other specified types of non-Hodgkin lymphoma, spleen"},{"code":"C85.88","display":"Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C85.89","display":"Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C85.90","display":"Non-Hodgkin lymphoma, unspecified, unspecified site"},{"code":"C85.91","display":"Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck"},{"code":"C85.92","display":"Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes"},{"code":"C85.93","display":"Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes"},{"code":"C85.94","display":"Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb"},{"code":"C85.95","display":"Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb"},{"code":"C85.96","display":"Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes"},{"code":"C85.97","display":"Non-Hodgkin lymphoma, unspecified, spleen"},{"code":"C85.98","display":"Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites"},{"code":"C85.99","display":"Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites"},{"code":"C86.0","display":"Extranodal NK/T-cell lymphoma, nasal type"},{"code":"C86.1","display":"Hepatosplenic T-cell lymphoma"},{"code":"C86.2","display":"Enteropathy-type (intestinal) T-cell lymphoma"},{"code":"C86.3","display":"Subcutaneous panniculitis-like T-cell lymphoma"},{"code":"C86.4","display":"Blastic NK-cell lymphoma"},{"code":"C86.6","display":"Primary cutaneous CD30-positive T-cell proliferations"},{"code":"C88.4","display":"Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]"},{"code":"C90.00","display":"Multiple myeloma not having achieved remission"},{"code":"C90.02","display":"Multiple myeloma in relapse"},{"code":"C90.10","display":"Plasma cell leukemia not having achieved remission"},{"code":"C90.12","display":"Plasma cell leukemia in relapse"},{"code":"C91.00","display":"Acute lymphoblastic leukemia not having achieved remission"},{"code":"C91.02","display":"Acute lymphoblastic leukemia, in relapse"},{"code":"C91.30","display":"Prolymphocytic leukemia of B-cell type not having achieved remission"},{"code":"C91.32","display":"Prolymphocytic leukemia of B-cell type, in relapse"},{"code":"C91.50","display":"Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission"},{"code":"C91.52","display":"Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse"},{"code":"C91.60","display":"Prolymphocytic leukemia of T-cell type not having achieved remission"},{"code":"C91.62","display":"Prolymphocytic leukemia of T-cell type, in relapse"},{"code":"C91.90","display":"Lymphoid leukemia, unspecified not having achieved remission"},{"code":"C91.92","display":"Lymphoid leukemia, unspecified, in relapse"},{"code":"C91.A0","display":"Mature B-cell leukemia Burkitt-type not having achieved remission"},{"code":"C91.A2","display":"Mature B-cell leukemia Burkitt-type, in relapse"},{"code":"C91.Z0","display":"Other lymphoid leukemia not having achieved remission"},{"code":"C91.Z2","display":"Other lymphoid leukemia, in relapse"},{"code":"C92.00","display":"Acute myeloblastic leukemia, not having achieved remission"},{"code":"C92.02","display":"Acute myeloblastic leukemia, in relapse"},{"code":"C92.10","display":"Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission"},{"code":"C92.12","display":"Chronic myeloid leukemia, BCR/ABL-positive, in relapse"},{"code":"C92.20","display":"Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission"},{"code":"C92.22","display":"Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse"},{"code":"C92.40","display":"Acute promyelocytic leukemia, not having achieved remission"},{"code":"C92.42","display":"Acute promyelocytic leukemia, in relapse"},{"code":"C92.50","display":"Acute myelomonocytic leukemia, not having achieved remission"},{"code":"C92.52","display":"Acute myelomonocytic leukemia, in relapse"},{"code":"C92.60","display":"Acute myeloid leukemia with 11q23-abnormality not having achieved remission"},{"code":"C92.62","display":"Acute myeloid leukemia with 11q23-abnormality in relapse"},{"code":"C92.90","display":"Myeloid leukemia, unspecified, not having achieved remission"},{"code":"C92.92","display":"Myeloid leukemia, unspecified in relapse"},{"code":"C92.A0","display":"Acute myeloid leukemia with multilineage dysplasia, not having achieved remission"},{"code":"C92.A2","display":"Acute myeloid leukemia with multilineage dysplasia, in relapse"},{"code":"C92.Z0","display":"Other myeloid leukemia not having achieved remission"},{"code":"C92.Z2","display":"Other myeloid leukemia, in relapse"},{"code":"C93.00","display":"Acute monoblastic/monocytic leukemia, not having achieved remission"},{"code":"C93.02","display":"Acute monoblastic/monocytic leukemia, in relapse"},{"code":"C93.10","display":"Chronic myelomonocytic leukemia not having achieved remission"},{"code":"C93.12","display":"Chronic myelomonocytic leukemia, in relapse"},{"code":"C93.30","display":"Juvenile myelomonocytic leukemia, not having achieved remission"},{"code":"C93.32","display":"Juvenile myelomonocytic leukemia, in relapse"},{"code":"C93.90","display":"Monocytic leukemia, unspecified, not having achieved remission"},{"code":"C93.92","display":"Monocytic leukemia, unspecified in relapse"},{"code":"C93.Z0","display":"Other monocytic leukemia, not having achieved remission"},{"code":"C93.Z2","display":"Other monocytic leukemia, in relapse"},{"code":"C94.20","display":"Acute megakaryoblastic leukemia not having achieved remission"},{"code":"C94.22","display":"Acute megakaryoblastic leukemia, in relapse"},{"code":"C94.30","display":"Mast cell leukemia not having achieved remission"},{"code":"C94.32","display":"Mast cell leukemia, in relapse"},{"code":"C94.80","display":"Other specified leukemias not having achieved remission"},{"code":"C94.82","display":"Other specified leukemias, in relapse"},{"code":"C95.00","display":"Acute leukemia of unspecified cell type not having achieved remission"},{"code":"C95.02","display":"Acute leukemia of unspecified cell type, in relapse"},{"code":"C95.10","display":"Chronic leukemia of unspecified cell type not having achieved remission"},{"code":"C95.12","display":"Chronic leukemia of unspecified cell type, in relapse"},{"code":"C95.90","display":"Leukemia, unspecified not having achieved remission"},{"code":"C95.92","display":"Leukemia, unspecified, in relapse"},{"code":"C96.4","display":"Sarcoma of dendritic cells (accessory cells)"},{"code":"C96.9","display":"Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified"},{"code":"C96.Z","display":"Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue"},{"code":"D46.9","display":"Myelodysplastic syndrome, unspecified"},{"code":"D46.Z","display":"Other myelodysplastic syndromes"},{"code":"D61.818","display":"Other pancytopenia"},{"code":"D70.0","display":"Congenital agranulocytosis"},{"code":"D70.3","display":"Neutropenia due to infection"},{"code":"D70.4","display":"Cyclic neutropenia"},{"code":"D70.8","display":"Other neutropenia"},{"code":"D70.9","display":"Neutropenia, unspecified"},{"code":"D73.81","display":"Neutropenic splenomegaly"},{"code":"D80.0","display":"Hereditary hypogammaglobulinemia"},{"code":"D80.1","display":"Nonfamilial hypogammaglobulinemia"},{"code":"D80.2","display":"Selective deficiency of immunoglobulin A [IgA]"},{"code":"D80.7","display":"Transient hypogammaglobulinemia of infancy"},{"code":"D80.8","display":"Other immunodeficiencies with predominantly antibody defects"},{"code":"D80.9","display":"Immunodeficiency with predominantly antibody defects, unspecified"},{"code":"D81.0","display":"Severe combined immunodeficiency [SCID] with reticular dysgenesis"},{"code":"D81.1","display":"Severe combined immunodeficiency [SCID] with low T- and B-cell numbers"},{"code":"D81.2","display":"Severe combined immunodeficiency [SCID] with low or normal B-cell numbers"},{"code":"D81.31","display":"Severe combined immunodeficiency due to adenosine deaminase deficiency"},{"code":"D81.89","display":"Other combined immunodeficiencies"},{"code":"D81.9","display":"Combined immunodeficiency, unspecified"},{"code":"D82.0","display":"Wiskott-Aldrich syndrome"},{"code":"D82.3","display":"Immunodeficiency following hereditary defective response to Epstein-Barr virus"},{"code":"D82.8","display":"Immunodeficiency associated with other specified major defects"},{"code":"D82.9","display":"Immunodeficiency associated with major defect, unspecified"},{"code":"D83.0","display":"Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function"},{"code":"D83.1","display":"Common variable immunodeficiency with predominant immunoregulatory T-cell disorders"},{"code":"D83.2","display":"Common variable immunodeficiency with autoantibodies to B- or T-cells"},{"code":"D83.8","display":"Other common variable immunodeficiencies"},{"code":"D83.9","display":"Common variable immunodeficiency, unspecified"},{"code":"D84.1","display":"Defects in the complement system"},{"code":"D84.8","display":"Other specified immunodeficiencies"},{"code":"D84.9","display":"Immunodeficiency, unspecified"},{"code":"E70.330","display":"Chediak-Higashi syndrome"}]}]}}